ZA866194B - Anticonvulsant compositions and method - Google Patents

Anticonvulsant compositions and method

Info

Publication number
ZA866194B
ZA866194B ZA866194A ZA866194A ZA866194B ZA 866194 B ZA866194 B ZA 866194B ZA 866194 A ZA866194 A ZA 866194A ZA 866194 A ZA866194 A ZA 866194A ZA 866194 B ZA866194 B ZA 866194B
Authority
ZA
South Africa
Prior art keywords
anticonvulsant
compositions
anticonvulsant compositions
Prior art date
Application number
ZA866194A
Other languages
English (en)
Inventor
Frank C Tortella
Jose M Musacchio
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of ZA866194B publication Critical patent/ZA866194B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA866194A 1985-08-16 1986-08-18 Anticonvulsant compositions and method ZA866194B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/766,838 US4694010A (en) 1985-08-16 1985-08-16 Anticonvulsant compositions and method

Publications (1)

Publication Number Publication Date
ZA866194B true ZA866194B (en) 1987-04-29

Family

ID=25077679

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA866194A ZA866194B (en) 1985-08-16 1986-08-18 Anticonvulsant compositions and method

Country Status (8)

Country Link
US (1) US4694010A (da)
EP (1) EP0233932A4 (da)
JP (1) JPS63500598A (da)
AU (1) AU579028B2 (da)
DK (1) DK178687D0 (da)
IL (1) IL79595A0 (da)
WO (1) WO1987001036A1 (da)
ZA (1) ZA866194B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4806543A (en) * 1986-11-25 1989-02-21 Board Of Trustees Of The Leland Stanford Junior University Method and compositions for reducing neurotoxic injury
AU2929489A (en) * 1987-12-22 1989-07-19 John W. FERKANY Dextrorphan potentiator for anticonvulsant composition and method
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
US5234929A (en) * 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
CA2264182A1 (en) * 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
WO1999008670A1 (en) 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
AU2002301362B8 (en) * 1997-09-08 2006-05-04 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
WO1999012537A1 (en) * 1997-09-08 1999-03-18 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
US6451857B1 (en) 1999-03-10 2002-09-17 Warner-Lambert Company Analgesic compositions comprising anti-epileptic compounds and methods of using same
US20040002543A1 (en) * 2001-02-16 2004-01-01 Leslie Magnus Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
MX341177B (es) 2007-05-01 2016-08-10 Concert Pharmaceuticals Inc Compuestos de morfina.
US7973049B2 (en) * 2007-05-01 2011-07-05 Concert Pharmaceuticals Inc. Morphinan compounds
FI3825306T3 (fi) 2007-05-01 2023-08-23 Concert Pharmaceuticals Inc Morfinaaniyhdisteitä
EP2334678B1 (en) 2008-09-19 2012-12-26 Concert Pharmaceuticals Inc. Morphinan compounds
EP4122919A1 (en) 2016-07-04 2023-01-25 Avanir Pharmaceuticals, Inc. Methods for the synthesis of deuterated dextromethorphan
CN108853502B (zh) * 2017-05-09 2024-06-14 浙江大学 治疗抑郁症的方法和药物组合物
CN115025227A (zh) * 2017-05-09 2022-09-09 浙江大学 联合用药治疗抑郁症的方法和药物组合物
WO2018205935A1 (zh) * 2017-05-09 2018-11-15 浙江大学 治疗抑郁症的方法和药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5227M (da) * 1966-03-18 1967-08-14
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain

Also Published As

Publication number Publication date
AU6283786A (en) 1987-03-10
AU579028B2 (en) 1988-11-10
IL79595A0 (en) 1986-11-30
US4694010A (en) 1987-09-15
EP0233932A1 (en) 1987-09-02
EP0233932A4 (en) 1988-04-26
DK178687A (da) 1987-04-08
JPS63500598A (ja) 1988-03-03
DK178687D0 (da) 1987-04-08
WO1987001036A1 (en) 1987-02-26

Similar Documents

Publication Publication Date Title
GB2177108B (en) Shampoo compositions and method
EP0183556A3 (en) Immunopotentiating agents and method
ZA866194B (en) Anticonvulsant compositions and method
ZA859339B (en) Processes and compositions
IL75325A0 (en) Immunostimulating agents containing certain substituted quinolone-carboxylic acids and their preparation
ZA875601B (en) Shampoo method and composition
GR860797B (en) Compounds and method
ZA866428B (en) Anticonvulsant method and formulations
GB2271665B (en) Thermoelectrochemical system and method
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
GR860078B (en) Spiro - dioxolanes - dithiolanes and oxothiolanes
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
GB2178768B (en) Hair softening method and compositions
ZA867244B (en) Nematicidal compositions and method
EP0230052A3 (en) Immunoamplifiers and related compositions
GB8520640D0 (en) Fastening method
EP0273571A3 (en) Separating-agents composition and method using same
GR861721B (en) Antibiotic method and formulations
EP0192481A3 (en) Transportation and construction method
DE3665866D1 (en) Method for silalactone preparation and use
PH20880A (en) Substituted benzoxepines and isochromanes
BG47569A1 (en) 1- thiocarbamoylmethylpyrolidene- 2- tion and method for its preparation
BG48273A1 (en) Polymerisationable oligoimide and method for its preparation
GR862408B (en) Method for preparing alkenylazoles and their application
GB8406038D0 (en) Composition and method